CDKN2A and neoplasm: Of the initial 311 tumor samples that were evaluated for HPV status, 94 (30 %) were scored ‘p16 positive.’ The inter-observer variability between the scoring of all tumor samples by two pathologists was 0.867 (kappa statistic, p < 0.001).